Clinical Trial Update: PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry

View source ↗

Summary

This clinical trial update describes PROMISE, a study evaluating percutaneous peripheral cannulation for minimally invasive heart valve surgery, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Heart Valve Disease
• Mitral Valve Disease
• Tricuspid Valve Disease

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Heart Valve Diseases, Mitral Valve Disease | Status: RECRUITING